Best in 7 days The Hidden Risks of BPC‑157: What Patients Need to Know About Contamination and Safety US$ 27.86 Sold : Login>>
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial US$ 24.31 Min. order: 1 piece ★★★★★ 4.8 (182 reviews) Sold : Login>>
GLP1 agonists: current and future landscape of clinical trials for patients with metabolic dysfunction US$ 27.50 Min. order: 1 piece ★★★★★ 4.3 (10 reviews) Sold : Login>>
CagriSema Reduces Blood Pressure in Adults With Overweight or Obesity: REDEFINE 1 US$ 22.39 Min. order: 1 piece ★★★★★ 4.4 (261 reviews) Sold : Login>>
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes US$ 28.08 Min. order: 1 piece ★★★★★ 5.0 (242 reviews) Sold : Login>>
Novo Nordisk's CagriSema Falls Short in Head-to-Head Trial vs Zepbound | Bryce Platt, PharmD posted on the topic US$ 25.42 Min. order: 1 piece ★★★★★ 4.0 (100 reviews) Sold : Login>>